Showing results (501-510 of 530) with videos related to

Sort By:
Pageof 53
Cancer Prevention Research (Philadelphia, Pa.)|April 17, 2025
Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 years of follow-up in the Diabetes Prevention ProgramBrandy M Heckman-Stoddard, Jill P Crandall, Sharon L Edelstein, et al.
Journal of the American Society of Nephrology : JASN|August 13, 2011
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgeryChirag R Parikh, Steven G Coca, Heather Thiessen-Philbrook, et al.
Cancer Medicine|May 22, 2019
Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cellsJessica Garcia, Anne-Sophie Wozny, Florence Geiguer, et al.
Kidney International|February 22, 2020
IL-6-mediated hepatocyte production is the primary source of plasma and urine neutrophil gelatinase-associated lipocalin during acute kidney injuryNataliya I Skrypnyk, Katja M Gist, Kayo Okamura, et al.
Oral Oncology|March 5, 2023
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC)Panagiota Economopoulou, Aris Spathis, Ioannis Kotsantis, et al.
Journal of Dental Education|June 4, 2020
Outcomes from the Health Resources and Services Administration's Dental Faculty Development ProgramJesse T Ungard, Ellen Beck, Emily A Byington, et al.
The American Journal of Clinical Nutrition|July 17, 2025
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes studyAshley H Tjaden, Audrey A Goldbaum, Sharon L Edelstein, et al.
The Lancet. Diabetes & Endocrinology|May 1, 2025
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trialWilliam C Knowler, Lindsay Doherty, Sharon L Edelstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 TrialJonathan M Loree, Anthony Dowers, Dongsheng Tu, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2021
Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome StudyRonald B Goldberg, Mark T Tripputi, Edward J Boyko, et al.
Pageof 53